Terms: = Pancreatic cancer AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990
4 results:
1. Antibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients Treated with Gemcitabine for Stage IV pancreatic cancer.
Corty RW; Langworthy BW; Fine JP; Buse JB; Sanoff HK; Lund JL
Oncologist; 2020 Jul; 25(7):579-584. PubMed ID: 32181968
[TBL] [Abstract] [Full Text] [Related]
2. Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study.
Yamaue H; Tsunoda T; Tani M; Miyazawa M; Yamao K; Mizuno N; Okusaka T; Ueno H; Boku N; Fukutomi A; Ishii H; Ohkawa S; Furukawa M; Maguchi H; Ikeda M; Togashi Y; Nishio K; Ohashi Y
Cancer Sci; 2015 Jul; 106(7):883-90. PubMed ID: 25867139
[TBL] [Abstract] [Full Text] [Related]
3. Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer.
Kohaar I; Porter-Gill P; Lenz P; Fu YP; Mumy A; Tang W; Apolo AB; Rothman N; Baris D; Schned AR; Ylaya K; Schwenn M; Johnson A; Jones M; Kida M; Silverman DT; Hewitt SM; Moore LE; Prokunina-Olsson L
J Natl Cancer Inst; 2013 Jan; 105(1):69-73. PubMed ID: 23266392
[TBL] [Abstract] [Full Text] [Related]
4. [Diffusion-weighted imaging of the pancreas].
Grünberg K; Grenacher L; Klauss M
Radiologe; 2011 Mar; 51(3):186-94. PubMed ID: 21305263
[TBL] [Abstract] [Full Text] [Related]
